Similar articles for PMID: 33820860

Year	Number of Results
1997	1
1998	1
1999	1
2003	1
2004	2
2005	1
2006	3
2007	2
2008	7
2009	2
2010	2
2011	6
2012	6
2013	3
2014	5
2015	8
2016	8
2017	5
2018	8
2019	6
2020	12
2021	9

1

Nuclear Medicine and Molecular Imaging in Nodal Staging and Surveillance of Ocular Melanoma: Case Reports and Review of the Literature.

Zurcher KS, Houghton OM, Shen JF, Seetharam M, Roarke MC, Yang M. Zurcher KS, et al. J Nucl Med Technol. 2021 Sep;49(3):275-280. doi: 10.2967/jnmt.120.260539. Epub 2021 Apr 5. J Nucl Med Technol. 2021. PMID: 33820860

2

Ultrasound, CT, MRI, or PET-CT for staging and re-staging of adults with cutaneous melanoma.

Dinnes J, Ferrante di Ruffano L, Takwoingi Y, Cheung ST, Nathan P, Matin RN, Chuchu N, Chan SA, Durack A, Bayliss SE, Gulati A, Patel L, Davenport C, Godfrey K, Subesinghe M, Traill Z, Deeks JJ, Williams HC; Cochrane Skin Cancer Diagnostic Test Accuracy Group. Dinnes J, et al. Cochrane Database Syst Rev. 2019 Jul 1;7(7):CD012806. doi: 10.1002/14651858.CD012806.pub2. Cochrane Database Syst Rev. 2019. PMID: 31260100 Free PMC article.

3

Role of nuclear medicine in the management of cutaneous malignant melanoma.

Belhocine TZ, Scott AM, Even-Sapir E, Urbain JL, Essner R. Belhocine TZ, et al. J Nucl Med. 2006 Jun;47(6):957-67. J Nucl Med. 2006. PMID: 16741305 Free article. Review.

4

Low efficacy of 18F-FDG PET for detection of uveal malignant melanoma compared with 123I-IMP SPECT.

Kato K, Kubota T, Ikeda M, Tadokoro M, Abe S, Nakano S, Nishino M, Kobayashi H, Ishigaki T. Kato K, et al. J Nucl Med. 2006 Mar;47(3):404-9. J Nucl Med. 2006. PMID: 16513608 Free article. Clinical Trial.

5

Whole body magnetic resonance with diffusion weighted sequence with body signal suppression compared to (18)F-FDG PET/CT in newly diagnosed lymphoma.

Ferrari C, Minoia C, Asabella AN, Nicoletti A, Altini C, Antonica F, Ficco M, Guarini A, Maggialetti N, Rubini G. Ferrari C, et al. Hell J Nucl Med. 2014 Jan-Apr;17 Suppl 1:40-9. Hell J Nucl Med. 2014. PMID: 24392468

6

Whole-body fluorine-18 fluordeoxyglucose positron emission tomography/computed tomography (FDG-PET/CT) in staging of advanced uveal melanoma.

Freudenberg LS, Schueler AO, Beyer T, Antoch G, Kühl H, Bornfeld N, Bockisch A, Egelhof T. Freudenberg LS, et al. Surv Ophthalmol. 2004 Sep-Oct;49(5):537-40. doi: 10.1016/j.survophthal.2004.06.008. Surv Ophthalmol. 2004. PMID: 15325198

7

Melanoma & nuclear medicine: new insights & advances.

Perissinotti A, Rietbergen DD, Vidal-Sicart S, Riera AA, Olmos RAV. Perissinotti A, et al. Melanoma Manag. 2018 Jun 28;5(1):MMT06. doi: 10.2217/mmt-2017-0022. eCollection 2018 Jun. Melanoma Manag. 2018. PMID: 30190932 Free PMC article. Review.

8

Can integrated 18F-FDG PET/MR replace sentinel lymph node resection in malignant melanoma?

Schaarschmidt BM, Grueneisen J, Stebner V, Klode J, Stoffels I, Umutlu L, Schadendorf D, Heusch P, Antoch G, Pöppel TD. Schaarschmidt BM, et al. Eur J Nucl Med Mol Imaging. 2018 Nov;45(12):2093-2102. doi: 10.1007/s00259-018-4061-9. Epub 2018 Jun 6. Eur J Nucl Med Mol Imaging. 2018. PMID: 29876618

9

Influence of (18)F-FDG PET/CT on therapy management in patients with stage III/IV malignant melanoma.

Schüle SC, Eigentler TK, Garbe C, la Fougère C, Nikolaou K, Pfannenberg C. Schüle SC, et al. Eur J Nucl Med Mol Imaging. 2016 Mar;43(3):482-8. doi: 10.1007/s00259-015-3187-2. Epub 2015 Sep 18. Eur J Nucl Med Mol Imaging. 2016. PMID: 26384681

10

Imaging in cutaneous melanoma.

Ho Shon IA, Chung DK, Saw RP, Thompson JF. Ho Shon IA, et al. Nucl Med Commun. 2008 Oct;29(10):847-76. doi: 10.1097/MNM.0b013e32830439fb. Nucl Med Commun. 2008. PMID: 18769303 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed